Product/Composition:- | Thymosin Alpha 1 |
---|---|
Strength:- | 1.6 mg/vial |
Form:- | Lyophilized Powder for Injection |
Reference Brands:- | Zadaxin® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Thymosin Alpha 1 Injection (Zadaxin® generic) is an immunomodulatory peptide used in hepatitis, cancer immunotherapy, and viral infections. Offered in 1.6 mg/vial lyophilized form, manufactured under EU-GMP/WHO-GMP standards. Ideal for B2B supply, tenders, and licensing, with full regulatory dossiers and stability data.
Thymosin Alpha 1 Injection is a synthetic thymic peptide with strong immunomodulatory properties, used as an adjunct therapy in chronic hepatitis B, hepatitis C, and immunodeficiency disorders. It enhances T-cell activity and antiviral responses, supporting immune regulation in liver disease and oncology patients. Supplied as a lyophilized powder (1.6 mg/vial), it is manufactured under EU-GMP or WHO-GMP standards. Ideal for B2B partnerships, hospital supply, and licensing across regulated and semi-regulated markets. Full CTD dossiers, stability data, and quality certifications are available to support registration in Europe, CIS, and other international markets.